The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest. It offers both quantitative and qualitative information.
The global Targeted DNA & RNA Sequencing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Targeted DNA & RNA Sequencing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Targeted DNA & RNA Sequencing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Targeted DNA & RNA Sequencing in Human Biomedical Research is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Targeted DNA & RNA Sequencing include Illumina, Inc., F. Hoffmann-La Roche Ltd, Agilent Technologies, GATC Biotech Ag, Oxford Nanopore Technologies, Thermo Fisher Scientific, Inc., DNASTAR Inc., QIAGEN and BGI, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Targeted DNA & RNA Sequencing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Targeted DNA & RNA Sequencing.
Report Scope
The Targeted DNA & RNA Sequencing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Targeted DNA & RNA Sequencing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Targeted DNA & RNA Sequencing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company (Partial List)
- Illumina, Inc.
- F. Hoffmann-La Roche Ltd
- Agilent Technologies
- GATC Biotech Ag
- Oxford Nanopore Technologies
- Thermo Fisher Scientific, Inc.
- DNASTAR Inc.
- QIAGEN
- BGI
- Perkin Elmer, Inc.
- Pacific Biosciences of California, Inc.
- Bio-Rad Laboratories, Inc.
- Integrated DNA Technologies, Inc.
- RainDance Technologies, Inc.
- PierianDx
- Genomatix GmbH
- Macrogen, Inc.
Segment by Type
- DNA-based Targeted Sequencing
- RNA-based Targeted Sequencing
Segment by Application
- Human Biomedical Research
- Plant & Animal Sciences
- Drug Discovery
- Others
By Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina)
- Middle East & Africa (Turkey, Saudi Arabia, UAE)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Targeted DNA & RNA Sequencing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Targeted DNA & RNA Sequencing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 DNA-based Targeted Sequencing
1.2.3 RNA-based Targeted Sequencing
1.3 Market by Application
1.3.1 Global Targeted DNA & RNA Sequencing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Human Biomedical Research
1.3.3 Plant & Animal Sciences
1.3.4 Drug Discovery
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Targeted DNA & RNA Sequencing Market Perspective (2019-2030)
2.2 Targeted DNA & RNA Sequencing Growth Trends by Region
2.2.1 Global Targeted DNA & RNA Sequencing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Targeted DNA & RNA Sequencing Historic Market Size by Region (2019-2024)
2.2.3 Targeted DNA & RNA Sequencing Forecasted Market Size by Region (2025-2030)
2.3 Targeted DNA & RNA Sequencing Market Dynamics
2.3.1 Targeted DNA & RNA Sequencing Industry Trends
2.3.2 Targeted DNA & RNA Sequencing Market Drivers
2.3.3 Targeted DNA & RNA Sequencing Market Challenges
2.3.4 Targeted DNA & RNA Sequencing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Targeted DNA & RNA Sequencing Players by Revenue
3.1.1 Global Top Targeted DNA & RNA Sequencing Players by Revenue (2019-2024)
3.1.2 Global Targeted DNA & RNA Sequencing Revenue Market Share by Players (2019-2024)
3.2 Global Targeted DNA & RNA Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Targeted DNA & RNA Sequencing Revenue
3.4 Global Targeted DNA & RNA Sequencing Market Concentration Ratio
3.4.1 Global Targeted DNA & RNA Sequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Targeted DNA & RNA Sequencing Revenue in 2023
3.5 Targeted DNA & RNA Sequencing Key Players Head office and Area Served
3.6 Key Players Targeted DNA & RNA Sequencing Product Solution and Service
3.7 Date of Enter into Targeted DNA & RNA Sequencing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Targeted DNA & RNA Sequencing Breakdown Data by Type
4.1 Global Targeted DNA & RNA Sequencing Historic Market Size by Type (2019-2024)
4.2 Global Targeted DNA & RNA Sequencing Forecasted Market Size by Type (2025-2030)
5 Targeted DNA & RNA Sequencing Breakdown Data by Application
5.1 Global Targeted DNA & RNA Sequencing Historic Market Size by Application (2019-2024)
5.2 Global Targeted DNA & RNA Sequencing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Targeted DNA & RNA Sequencing Market Size (2019-2030)
6.2 North America Targeted DNA & RNA Sequencing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Targeted DNA & RNA Sequencing Market Size by Country (2019-2024)
6.4 North America Targeted DNA & RNA Sequencing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Targeted DNA & RNA Sequencing Market Size (2019-2030)
7.2 Europe Targeted DNA & RNA Sequencing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Targeted DNA & RNA Sequencing Market Size by Country (2019-2024)
7.4 Europe Targeted DNA & RNA Sequencing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Targeted DNA & RNA Sequencing Market Size (2019-2030)
8.2 Asia-Pacific Targeted DNA & RNA Sequencing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Targeted DNA & RNA Sequencing Market Size by Region (2019-2024)
8.4 Asia-Pacific Targeted DNA & RNA Sequencing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Targeted DNA & RNA Sequencing Market Size (2019-2030)
9.2 Latin America Targeted DNA & RNA Sequencing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Targeted DNA & RNA Sequencing Market Size by Country (2019-2024)
9.4 Latin America Targeted DNA & RNA Sequencing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Targeted DNA & RNA Sequencing Market Size (2019-2030)
10.2 Middle East & Africa Targeted DNA & RNA Sequencing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Targeted DNA & RNA Sequencing Market Size by Country (2019-2024)
10.4 Middle East & Africa Targeted DNA & RNA Sequencing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Illumina, Inc.
11.1.1 Illumina, Inc. Company Detail
11.1.2 Illumina, Inc. Business Overview
11.1.3 Illumina, Inc. Targeted DNA & RNA Sequencing Introduction
11.1.4 Illumina, Inc. Revenue in Targeted DNA & RNA Sequencing Business (2019-2024)
11.1.5 Illumina, Inc. Recent Development
11.2 F. Hoffmann-La Roche Ltd
11.2.1 F. Hoffmann-La Roche Ltd Company Detail
11.2.2 F. Hoffmann-La Roche Ltd Business Overview
11.2.3 F. Hoffmann-La Roche Ltd Targeted DNA & RNA Sequencing Introduction
11.2.4 F. Hoffmann-La Roche Ltd Revenue in Targeted DNA & RNA Sequencing Business (2019-2024)
11.2.5 F. Hoffmann-La Roche Ltd Recent Development
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Detail
11.3.2 Agilent Technologies Business Overview
11.3.3 Agilent Technologies Targeted DNA & RNA Sequencing Introduction
11.3.4 Agilent Technologies Revenue in Targeted DNA & RNA Sequencing Business (2019-2024)
11.3.5 Agilent Technologies Recent Development
11.4 GATC Biotech Ag
11.4.1 GATC Biotech Ag Company Detail
11.4.2 GATC Biotech Ag Business Overview
11.4.3 GATC Biotech Ag Targeted DNA & RNA Sequencing Introduction
11.4.4 GATC Biotech Ag Revenue in Targeted DNA & RNA Sequencing Business (2019-2024)
11.4.5 GATC Biotech Ag Recent Development
11.5 Oxford Nanopore Technologies
11.5.1 Oxford Nanopore Technologies Company Detail
11.5.2 Oxford Nanopore Technologies Business Overview
11.5.3 Oxford Nanopore Technologies Targeted DNA & RNA Sequencing Introduction
11.5.4 Oxford Nanopore Technologies Revenue in Targeted DNA & RNA Sequencing Business (2019-2024)
11.5.5 Oxford Nanopore Technologies Recent Development
11.6 Thermo Fisher Scientific, Inc.
11.6.1 Thermo Fisher Scientific, Inc. Company Detail
11.6.2 Thermo Fisher Scientific, Inc. Business Overview
11.6.3 Thermo Fisher Scientific, Inc. Targeted DNA & RNA Sequencing Introduction
11.6.4 Thermo Fisher Scientific, Inc. Revenue in Targeted DNA & RNA Sequencing Business (2019-2024)
11.6.5 Thermo Fisher Scientific, Inc. Recent Development
11.7 DNASTAR Inc.
11.7.1 DNASTAR Inc. Company Detail
11.7.2 DNASTAR Inc. Business Overview
11.7.3 DNASTAR Inc. Targeted DNA & RNA Sequencing Introduction
11.7.4 DNASTAR Inc. Revenue in Targeted DNA & RNA Sequencing Business (2019-2024)
11.7.5 DNASTAR Inc. Recent Development
11.8 QIAGEN
11.8.1 QIAGEN Company Detail
11.8.2 QIAGEN Business Overview
11.8.3 QIAGEN Targeted DNA & RNA Sequencing Introduction
11.8.4 QIAGEN Revenue in Targeted DNA & RNA Sequencing Business (2019-2024)
11.8.5 QIAGEN Recent Development
11.9 BGI
11.9.1 BGI Company Detail
11.9.2 BGI Business Overview
11.9.3 BGI Targeted DNA & RNA Sequencing Introduction
11.9.4 BGI Revenue in Targeted DNA & RNA Sequencing Business (2019-2024)
11.9.5 BGI Recent Development
11.10 Perkin Elmer, Inc.
11.10.1 Perkin Elmer, Inc. Company Detail
11.10.2 Perkin Elmer, Inc. Business Overview
11.10.3 Perkin Elmer, Inc. Targeted DNA & RNA Sequencing Introduction
11.10.4 Perkin Elmer, Inc. Revenue in Targeted DNA & RNA Sequencing Business (2019-2024)
11.10.5 Perkin Elmer, Inc. Recent Development
11.11 Pacific Biosciences of California, Inc.
11.11.1 Pacific Biosciences of California, Inc. Company Detail
11.11.2 Pacific Biosciences of California, Inc. Business Overview
11.11.3 Pacific Biosciences of California, Inc. Targeted DNA & RNA Sequencing Introduction
11.11.4 Pacific Biosciences of California, Inc. Revenue in Targeted DNA & RNA Sequencing Business (2019-2024)
11.11.5 Pacific Biosciences of California, Inc. Recent Development
11.12 Bio-Rad Laboratories, Inc.
11.12.1 Bio-Rad Laboratories, Inc. Company Detail
11.12.2 Bio-Rad Laboratories, Inc. Business Overview
11.12.3 Bio-Rad Laboratories, Inc. Targeted DNA & RNA Sequencing Introduction
11.12.4 Bio-Rad Laboratories, Inc. Revenue in Targeted DNA & RNA Sequencing Business (2019-2024)
11.12.5 Bio-Rad Laboratories, Inc. Recent Development
11.13 Integrated DNA Technologies, Inc.
11.13.1 Integrated DNA Technologies, Inc. Company Detail
11.13.2 Integrated DNA Technologies, Inc. Business Overview
11.13.3 Integrated DNA Technologies, Inc. Targeted DNA & RNA Sequencing Introduction
11.13.4 Integrated DNA Technologies, Inc. Revenue in Targeted DNA & RNA Sequencing Business (2019-2024)
11.13.5 Integrated DNA Technologies, Inc. Recent Development
11.14 RainDance Technologies, Inc.
11.14.1 RainDance Technologies, Inc. Company Detail
11.14.2 RainDance Technologies, Inc. Business Overview
11.14.3 RainDance Technologies, Inc. Targeted DNA & RNA Sequencing Introduction
11.14.4 RainDance Technologies, Inc. Revenue in Targeted DNA & RNA Sequencing Business (2019-2024)
11.14.5 RainDance Technologies, Inc. Recent Development
11.15 PierianDx
11.15.1 PierianDx Company Detail
11.15.2 PierianDx Business Overview
11.15.3 PierianDx Targeted DNA & RNA Sequencing Introduction
11.15.4 PierianDx Revenue in Targeted DNA & RNA Sequencing Business (2019-2024)
11.15.5 PierianDx Recent Development
11.16 Genomatix GmbH
11.16.1 Genomatix GmbH Company Detail
11.16.2 Genomatix GmbH Business Overview
11.16.3 Genomatix GmbH Targeted DNA & RNA Sequencing Introduction
11.16.4 Genomatix GmbH Revenue in Targeted DNA & RNA Sequencing Business (2019-2024)
11.16.5 Genomatix GmbH Recent Development
11.17 Macrogen, Inc.
11.17.1 Macrogen, Inc. Company Detail
11.17.2 Macrogen, Inc. Business Overview
11.17.3 Macrogen, Inc. Targeted DNA & RNA Sequencing Introduction
11.17.4 Macrogen, Inc. Revenue in Targeted DNA & RNA Sequencing Business (2019-2024)
11.17.5 Macrogen, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
